The predominant role assigned to the estrogen receptor (ER)-α pathway as the key player in the origin and maintenance of the neoplastic phenotype in mammary cancer has been challenged by recent clinical [1-4] and experimental [5] findings, which suggest that progesterone receptors (PRs) play a similarly significant role. The gene discussed is PGR; the disease is breast cancer.